Amarin Corporation plc Company Profile
NASDAQ: AMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Amarin at a glance
Amarin Corporation plc (NASDAQ: AMRN) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Dublin, Ireland. Amarin is led by Mr. Aaron D. Berg and employs about 80 people. At a market capitalization of $253.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000897448, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Amarin do?
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Business description based on the company's public filings.
Company information
- Legal name
- Amarin Corporation plc
- Ticker
- NASDAQ: AMRN
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Aaron D. Berg
- Employees
- 80
- Headquarters
- One Central Plaza, Dublin, Ireland
- Phone
- 353 0 166 99020
- Website
- amarincorp.com
- Market cap
- $253.90M
- SEC CIK
- 0000897448
Companies similar to Amarin
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ACIUAC Immune SA | 2.55 | -0.78% | $253.54M | vs AMRN |
| VCREVicore Pharma Holding AB ADR | 8.82 | +1.85% | $248.41M | vs AMRN |
| VOGXVogenx Inc | 17.49 | +8.23% | $259.82M | vs AMRN |
| LFCRLifecore Biomedical Inc. | 6.43 | -0.16% | $243.73M | vs AMRN |
| IMRXImmuneering Corporation Class A | 3.74 | -3.11% | $241.97M | vs AMRN |
| QTTBQ32 Bio Inc. | 8.09 | +1.25% | $240.83M | vs AMRN |
| SIGASIGA Technologies Inc. | 3.28 | +0.61% | $235.67M | vs AMRN |
| BBOTBridgeBio Oncology Therapeutics Inc. | 3.42 | -0.58% | $274.20M | vs AMRN |